We develop sterile drug products with scalability and GMP readiness in mind—combining formulation development, process development, selection of primary packaging, and analytical support into one integrated workflow. Our services also includes lyophilized nanoparticle formulation cycle development. During development, we define a robust manufacturing process, critical process parameters, hold times, and sterile filtration approaches. In parallel, we evaluate primary packaging and container-closure systems to ensure compatibility, stability, and a reliable fill and finish strategy.
